Shinichiro Nakamura

Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial

Shukui Qin, Minshan Chen, Ann‐Lii Cheng et al. · The Lancet · 2023 · 488 citations · Full text

Medicine, Oncology, Pharmacotherapy +14

The ROCK Inhibitor Eye Drop Accelerates Corneal Endothelium Wound Healing

Naoki Okumura, Noriko Koizumi, EunDuck P. Kay et al. · Investigative Ophthalmology & Visual Science · 2013 · 243 citations

Medicine, Ophthalmology, Surgery +13

Sensitivity and Specificity of Des-Gamma-Carboxy Prothrombin for Diagnosis of Patients with Hepatocellular Carcinomas Varies According to Tumor Size

Shinichiro Nakamura, Kazuhiro Nouso, Kohsaku Sakaguchi et al. · The American Journal of Gastroenterology · 2006 · 164 citations

Medicine, Oncology, Pathology +17

Potential Role of Hepatocyte Growth Factor, a Novel Angiogenic Growth Factor, in Peripheral Arterial Disease : Downregulation of HGF in Response to Hypoxia in Vascular Cells

S. Hayashi, R. Morishita, Shinichiro Nakamura et al. · Circulation · 1999 · 130 citations

Life Sciences, Pathobiology, Physiology +17

Atezolizumab plus bevacizumab versus lenvatinib or sorafenib in non-viral unresectable hepatocellular carcinoma: an international propensity score matching analysis

Margherita Rimini, Lorenza Rimassa, Kazuomi Ueshima et al. · ESMO Open · 2022 · 130 citations · Full text

Pharmacy, Oncology, Pharmacotherapy +14